Association between facility characteristics and the provision of timely and appropriate empiric antibiotics for neonatal sepsis (adjusted OR (95% CI))
| All cases (n=821) | Cases seen at facilities included at both baseline and follow-up (n=616) | Cases seen at complete-level facilities only (n=622) | |
| Complete-level facility | 0.68 (0.23 to 2.02) | 0.26 (0.05 to 1.29) | Omitted |
| Country | |||
| Belize | 0.99 (0.57 to 1.73) | 0.90 (0.46 to 1.79) | 0.94 (0.57 to 1.55) |
| Guatemala | 0.39 (0.20 to 0.77) | 0.42 (0.19 to 0.94) | 0.37 (0.18 to 0.76) |
| Honduras | Ref | Ref | Ref |
| Mexico | 0.13 (0.06 to 0.30) | 0.11 (0.04 to 0.31) | 0.08 (0.02 to 0.26) |
| Nicaragua | 0.18 (0.05 to 0.60) | 0.05 (0.01 to 0.29) | 0.04 (0.00 to 0.35) |
| Paediatrician on staff | 3.19 (0.40 to 25.76) | 1.16 (0.21 to 6.56) | 0.54 (0.17 to 1.78) |
| Relevant training* within prior 12 months | 0.57 (0.26 to 1.24) | 0.51 (0.19 to 1.34) | 0.43 (0.18 to 1.06) |
| Availability of appropriate antibiotic combination | 5.36 (2.85 to 10.08) | 7.40 (3.01 to 18.15) | 6.95 (2.66 to 18.16) |
| 18-month follow-up | 0.32 (0.15 to 0.68) | 0.27 (0.09 to 0.81) | 0.26 (0.09 to 0.78) |
*Relevant training includes IMCI/AIEPI/management of neonatal complications.
IMCI, integrated management of childhood illnesses.